The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection

Lancet Infectious Diseases

Volumn 7, Issue 4, 2007, Pages 282-288

  Stone, Sheldon P ^a   Cooper, Ben S ^b   Kibbler, Chris C ^a   Cookson, Barry D ^b   Roberts, Jenny A ^c   Medley, Graham F ^d   Duckworth, Georgia ^b   Lai, Rosalind ^a   Ebrahim, Shah ^c   Brown, Erwin M ^e   Wiffen, Phil J ^f   Davey, Peter G ^g  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY OF WARWICK   (United Kingdom)

^e FRENCHAY HOSPITAL   (United Kingdom)

^f UK COCHRANE CENTRE   (United Kingdom)

^g UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDEMIC; HEALTH CARE POLICY; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INTERVENTION STUDY; MEDICAL DOCUMENTATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS;

CROSS INFECTION; DISEASE NOTIFICATION; DISEASE OUTBREAKS; GUIDELINES; HUMANS; INFECTION CONTROL;

EID: 33947210035     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(07)70082-8     Document Type: Review

References (30)

1. Begg C., Cho M., Eastwood S., et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 276 (1996) 637-639
2. Moher D., Schulz K., Altman D., and for the CONSORT group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357 (2001) 1191-1194
3. Campbell M., Elbourne D., Altman D., and for the CONSORT group. CONSORT statement: extension to cluster randomised trials. BMJ 328 (2004) 702-708
4. Des Jarlais D., Lyles C., Crepaz N., and the TREND Group. Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health 94 (2004) 361-366
5. Kirkwood B. Making public health interventions more evidence based. BMJ 328 (2004) 966-967
6. Cooper B., Stone S., Kibbler C., et al. Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling. Health Technol Assess 7 (2003) 1-194
7. Cooper B., Stone S., Kibbler C., et al. Isolation measures in the hospital management of MRSA: a systematic review of the literature. BMJ 329 (2004) 533-538
8. Ramsay C., Brown E., Hartman G., and Davey P. Room for improvement: a systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing. J Antimicrob Chemother 52 (2003) 764-771
9. Davey P., Brown E., Fenelon L., et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 4 (2005) CD003543.
10. Harris A., Lautenbach E., and Perencevich E. A systematic review of quasi-experimental study designs in the fields of infection control and antibiotic resistance. Clin Infect Dis 41 (2005) 77-82
11. Cook T., and Campbell D. Quasi experimentation. Design and analysis issues for field settings. 1st edn. (1979), Houghton Mifflin Company, Boston, MA, USA
12. Effective Practice and Organisation of Care Group. http://www.epoc.uottawa.ca/index.htm (accessed Feb 26, 2007).
13. Wagner A., Soumerai S., Zhang F., and Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 27 (2002) 299-309
14. Cepeda J., Whitehouse T., Cooper B., et al. Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. Lancet 365 (2005) 295-304
15. Fowler S., Webber A., Cooper B., et al. Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series. J Antimicrob Chemother (2007). DOI:10.1093/jac/dkm014
16. Grimes D., and Schulz K. Descriptive studies: what they can and cannot do. Lancet 359 (2002) 145-149
17. Cox R., Conquest C., Mallaghan C., and Marples R. A major outbreak of methicillin-resistant Staphylococcus aureus caused by a new phage-type (EMRSA-16). J Hosp Infect 29 (1995) 87-106
18. Cartmill T., Panigrahi H., Worsley M., McCann D., Nice C., and Keith E. Management and control of a large outbreak of diarrhoea due to Clostridium difficile. J Hosp Infect 27 (1994) 1-15
19. Reingold A. Outbreak investigations-a perspective. Emerg Infect Dis 4 (1998) 21-27
20. Morton V., and Torgerson D. Effect of regression to the mean on decision making in health care. BMJ 326 (2003) 1083-1084
21. Coia J., Duckworth G., Edwards D., et al. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 63 suppl 1 (2006) S1-S44
22. Bell S. Recommendations for control of the spread of methicillin resistant Staphylococcus aureus infection based on 18 years' experience in a group of teaching hospitals. Med J Aust 1 (1982) 472-474
23. MRC Health Services and Public Health Research Board. A framework for development and evaluation of RCTs for complex interventions to improve health, 2000. http://www.mrc.ac.uk/utilities/Documentrecord/index.htm?d=MRC003372 (accessed Feb 26, 2007).
24. Grimshaw J., Thomas R., MacLennan G., et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 8 (2004) 1-72
25. Plowman R., Graves N., Griffin M., et al. The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect 47 (2001) 198-209
26. Graves N. Economics and preventing hospital-acquired infection. Emerg Infect Dis 10 (2004) 561-565
27. Ioannidis J., Evans S., Gotzsche P., et al. Better reporting of harms in randomised trials: an extension of the CONSORT statement. Ann Intern Med 141 (2004) 781-788
28. Mayon-White R., and Wiffen P. Audit of antibiotic policies in the south east of England, 2004. J Antimicrob Chemother 56 (2005) 204-207
29. Altman D., and Moher D. Developing guidelines for reporting healthcare research: scientific rationale and procedures. Med Clin (Barc) 125 suppl 1 (2005) 8-13 (in Spanish).
30. Moher D., Jones A., Lepage L., and for the CONSORT group. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before and after evaluation. JAMA 285 (2001) 1992-1995